Pertrochanteric Fracture. Pertrochanteric fracture
Conditions
Interventions
Intervention 1: Control group: In addition to the post-protocol, daily calcium carbonate supplement for one month (totally, 30 tablets), Alendronate 70 mg once a week for three months (totally, 12 tab
Sponsors
Daroo Salamat Pharmed
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients over 65 years referred to Trauma Emergency of Shariati Hospital with pertrochanteric fracture who are candidates for surgery
Exclusion criteria
Exclusion criteria: Patients who are not candidates for surgery due to medical problems with an ASA score of 3 or higher Patients receiving osteoporosis treatments including bisphosphonates, calcium and vitamin D supplements, or hormone therapy prior to surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Rate Score. Timepoint: Immediately after surgery, 3 months after surgery, 6 months after surgery. Method of measurement: Visual Analog Scale Questionnaire.;Bone Mineral Density. Timepoint: Immediately after surgery, 6 months after surgery. Method of measurement: Bone-marrow densitometry.;Fracture Union. Timepoint: Every month. Method of measurement: Radiography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Possible side effects of the drug. Timepoint: 3 months after surgery, 6 months after surgery. Method of measurement: Patient's Record and History.;Quadriceps Muscle Strength. Timepoint: After surgery, Third months follow-up, Sixth month follow-up. Method of measurement: Motor Function Measure.;Weight Bearing Time. Timepoint: 3 months after surgery, 6 months after surgery. Method of measurement: Patient's Record and History. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Negar Mosavi Hasab
Daroo Salamat Pharmed
Outcome results
None listed